Bhawandeep Garg1, Deepak Sharma2, Anju Bansal3. 1. a Department of Neonatology , Surya Children's Medicare Pvt. Ltd , Mumbai , India. 2. b Department of Neonatology , National Institute of Medical and Sciences , Jaipur , India. 3. c Department of Surgery , Adarsh Hospital , Sri Ganganagar , India.
Abstract
BACKGROUND: Hypoxic ischemic encephalopathy (HIE) is one of the leading causes of neonatal mortality in developing countries and leads to some form of neuro-developmental disability in latter part of life. AIMS: The aim of this study is to evaluate the role of erythropoietin (EPO) in neuroprotection for term newborn having HIE. METHOD: The literature search was done for various trials by searching the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of science, Scopus, Index Copernicus, and other database. RESULTS: A total of nine studies fulfilled inclusion criteria. EPO has shown to cause reduction in death and disability, better long-term neuro-developmental outcome, improvement in EEG, and reduction in risk of cerebral palsy. CONCLUSION: EPO treatment has neuroprotective effects against moderate/severe HIE and improves long-term behavioral neurological developments in neonates.
BACKGROUND:Hypoxic ischemicencephalopathy (HIE) is one of the leading causes of neonatal mortality in developing countries and leads to some form of neuro-developmental disability in latter part of life. AIMS: The aim of this study is to evaluate the role of erythropoietin (EPO) in neuroprotection for term newborn having HIE. METHOD: The literature search was done for various trials by searching the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of science, Scopus, Index Copernicus, and other database. RESULTS: A total of nine studies fulfilled inclusion criteria. EPO has shown to cause reduction in death and disability, better long-term neuro-developmental outcome, improvement in EEG, and reduction in risk of cerebral palsy. CONCLUSION:EPO treatment has neuroprotective effects against moderate/severe HIE and improves long-term behavioral neurological developments in neonates.
Authors: Sandra E Juul; Bryan A Comstock; Patrick J Heagerty; Dennis E Mayock; Amy M Goodman; Stephanie Hauge; Fernando Gonzalez; Yvonne W Wu Journal: Neonatology Date: 2018-03-07 Impact factor: 4.035
Authors: Willemien S Kalteren; Hendrik J Ter Horst; Anne E den Heijer; Leanne de Vetten; Elisabeth M W Kooi; Arend F Bos Journal: Neonatology Date: 2018-07-19 Impact factor: 4.035
Authors: A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak Journal: Physiol Res Date: 2020-12-31 Impact factor: 1.881